PeptideDB

SC-2001

CAS: 1383727-17-0 F: C18H14BrN3O W: 368.23

SC-2001 is a compound structurally related to obatoclax that has better antitumor effects than obatoclax in liver cancer
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity SC-2001 is a compound structurally related to obatoclax that has better antitumor effects than obatoclax in liver cancer cell lines, downregulating Mcl-1 protein levels, inhibiting STAT3 phosphorylation, inducing apoptosis, and enhancing SHP1 expression and activity.
CAS 1383727-17-0
Formula C18H14BrN3O
Molar Mass 368.23
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation